| investr...@aol.com (InvestRptr) wrote: ****************************************************************** **INVESTMENT REPORTER MAGAZINE** June 1, 1995 Vol. I, No. 1 TOMAHAWK MISSILE TECHNOLOGY HAS A UNIQUE PATENTED APPLICATION FOR A WIDELY USED MEDICAL DIAGNOSTICS TECHNIQUE. Profile Company: Papnet of Ohio Inc. NASDAQ Bulletin Board Symbol: PPNT Recent Price: 15 1995 Price Range: Hi - 20 Lo - 6 1/2 If a computer in a cruise missile can find an enemy tank in the Desert of Kuwait, then why cant the same technology be used to find an abnormal cell in a microscopic slide prepared for a Pap smear? Interesting point, except cruise missiles cant find tanks in a desert! (Tomahawks were used against stationary targets like communication centers etc..) |
| In addition, we are offering *The Private List*, a flat fee online investment advisory service, for an introductory price we believe is attractive. *The Private List* is not a newsletter. It is advice to *you* about *your* portfolio. For details on *The Private List*, please send an e-mail reply to: g...@nyct.net. |
| We emphasize safety and medium to long term investment. There is no sense in throwing miney away on gambles. Mining sector is one which does well in bear markets. |
| -Cliff clif...@airmail.net (no Web site, and no sales pitch, sorry) I chose to include my "signature" in this particular, and included Reynolds Russells "signature" in the quoted-text (despite the general practice of deleting previous "signatures" in follow-ups) to illustrate that this is the accepted and proper means of conveying commercial information. Regarding SAUERS WWW SITES FOR INVESTORS, it is not a commercial advertisement offering an investment-related product or service. It is a compilation of websites offering free information to investors that is contributed to the misc.invest.* newsgroups. You will note that it is _not_ posted to misc.invest.marketplace! And finally, I am not "raging on about advertising in this newsgroup". It is the readers of these newsgroups that voted a "no advertisements" clause into the charters when they were recently reorganized. Okay, now we can all get back to reading th. |
| This licensing arrangement allows Papnet of Ohio, Inc. to operate with very little overhead and no future large capital investment. The Company believes that FDA approval will come in 1995. With this approval the PAPNET System could rapidly become the standard of care for screening Pap smears. If this does occur, the company could possibly see cash flow per share reach $10.00. |
